Free Trial

Aehr Test Systems (NASDAQ:AEHR) Stock Passes Above 200 Day Moving Average - Time to Sell?

Aehr Test Systems logo with Computer and Technology background

Key Points

  • Aehr Test Systems shares have crossed above their 200-day moving average, indicating potential upward momentum in trading.
  • Wall Street analysts have recently upgraded the stock to a "sell" rating amidst concerns about the company's performance.
  • Insider trading activity has been notable, with significant share sales by key executives, indicating potential cautious sentiment regarding the stock.
  • MarketBeat previews the top five stocks to own by October 1st.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $11.51 and traded as high as $19.83. Aehr Test Systems shares last traded at $17.59, with a volume of 1,846,454 shares.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised Aehr Test Systems to a "sell" rating in a report on Tuesday, May 13th.

Read Our Latest Analysis on AEHR

Aehr Test Systems Stock Up 35.9%

The company has a market cap of $735.73 million, a P/E ratio of -189.14 and a beta of 2.35. The firm has a fifty day moving average price of $16.38 and a 200 day moving average price of $11.75.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 8th. The semiconductor company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.01. Aehr Test Systems had a negative net margin of 6.63% and a negative return on equity of 0.15%. The business had revenue of $14,100 billion for the quarter, compared to the consensus estimate of $14.83 million. On average, sell-side analysts anticipate that Aehr Test Systems will post 0.1 earnings per share for the current year.

Insider Activity at Aehr Test Systems

In other news, VP Alistair N. Sporck sold 3,000 shares of the company's stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $14.13, for a total transaction of $42,390.00. Following the transaction, the vice president owned 30,808 shares of the company's stock, valued at $435,317.04. This represents a 8.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Rhea J. Posedel sold 18,000 shares of the firm's stock in a transaction dated Tuesday, July 22nd. The shares were sold at an average price of $19.83, for a total value of $356,940.00. Following the completion of the transaction, the director owned 71,163 shares in the company, valued at approximately $1,411,162.29. This represents a 20.19% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 26,000 shares of company stock valued at $506,830 over the last quarter. Corporate insiders own 6.20% of the company's stock.

Institutional Trading of Aehr Test Systems

Several institutional investors and hedge funds have recently added to or reduced their stakes in AEHR. JPMorgan Chase & Co. boosted its stake in shares of Aehr Test Systems by 15.4% in the 4th quarter. JPMorgan Chase & Co. now owns 15,591 shares of the semiconductor company's stock valued at $259,000 after purchasing an additional 2,076 shares during the last quarter. Wells Fargo & Company MN raised its stake in shares of Aehr Test Systems by 81.7% during the fourth quarter. Wells Fargo & Company MN now owns 17,856 shares of the semiconductor company's stock worth $297,000 after buying an additional 8,027 shares during the last quarter. Invesco Ltd. lifted its holdings in Aehr Test Systems by 7.9% in the fourth quarter. Invesco Ltd. now owns 16,007 shares of the semiconductor company's stock valued at $266,000 after buying an additional 1,172 shares during the period. Raymond James Financial Inc. acquired a new position in Aehr Test Systems in the fourth quarter valued at approximately $272,000. Finally, Mariner LLC bought a new position in Aehr Test Systems in the fourth quarter valued at approximately $180,000. 69.69% of the stock is owned by institutional investors.

About Aehr Test Systems

(Get Free Report)

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.

Featured Stories

Should You Invest $1,000 in Aehr Test Systems Right Now?

Before you consider Aehr Test Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aehr Test Systems wasn't on the list.

While Aehr Test Systems currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.